Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

As FAUCI Movie Premieres, Pyxis Partners Salutes Dr. Anthony Fauci, Directors Janet Tobias & John Hoffman, And CEO Michael Manganiello

Manganiello, longtime leader in the HIV/AIDS Movement, featured in major new documentary from National Geographic


News provided by

Pyxis Partners

Sep 08, 2021, 11:30 ET

Share this article

Share toX

Share this article

Share toX

WASHINGTON, Sept. 8, 2021 /PRNewswire/ -- Pyxis Partners is proud to recognize founder and CEO Michael Manganiello ahead of this week's theatrical debut of FAUCI, a major new feature documentary about the nation's top infectious disease expert and dedicated public servant Dr. Anthony Fauci, M.D. Produced by National Geographic Documentary Films and Magnolia Pictures, and featuring insight and commentary from Manganiello, the movie is a rare glimpse into the long-standing professional career and personal life of the ultimate public servant and healthcare leader.

Continue Reading
Pyxis Partners is proud to recognize founder and CEO Michael Manganiello's insight and commentary in theatrical debut of FAUCI, a major new feature documentary about the nation’s top infectious disease expert and dedicated public servant Dr. Anthony Fauci, M.D.
Pyxis Partners is proud to recognize founder and CEO Michael Manganiello's insight and commentary in theatrical debut of FAUCI, a major new feature documentary about the nation’s top infectious disease expert and dedicated public servant Dr. Anthony Fauci, M.D.

"The chance to speak about my experiences with Dr. Fauci during my time at the NIH in the early days of AIDS is the opportunity of a lifetime," said Manganiello, a longtime leader in the AIDS and civil rights movement and a 35-year survivor of the AIDS epidemic. "It's not often that you have the opportunity to publicly thank the person who saved your life. Professionally he represents so much of what we strive to embody at Pyxis Partners — patient impact, healthcare equity, and policy leadership."

Manganiello's insights — featured alongside those of Bono, Bill Gates, George W. Bush, Susan Rice, Francis Collins, Tom Frieden, and Clifford Lane, among others — are focused on his experience participating in the early trials for AIDS research.

"I'll never forget the climate that Dr. Fauci and the NIH created at the Clinical Center on the NIH campus," said Manganiello. "It was free of stigma and judgement and the swirling politics that surrounded AIDS in the early days. Dr. Fauci and the NIH created a safe space that offered so many of us hope. For me, it helped shape my personal path — seeking to advance scientific research in the service of future generations and going on to work with my mentors Christopher and Dana Reeve, driving to cure spinal cord injury through their foundation."

The film is directed by John Hoffman and Janet Tobias, who have spent their careers telling important and compelling stories in the documentary space about science and public health. Over the past 36 years, Hoffman has made a specialty of communicating to a concerned public about disease, starting with HIV prevention and then addiction, Alzheimer's, obesity, sleep, and the role of the NIH in leading the way on medical breakthroughs. Tobias' recent film, Unseen Enemy, sounded a warning call about the threat of pandemics, which should not have gone unheeded.

"It was critical to have Michael, one of Tony's former patients — a man who was and is also an important AIDS and health activist — in our film," said Tobias. Manganiello will be appearing in a post-show discussion with Tobias at the Angelika Film Center in Washington, D.C. following showings of the movie Saturday, September 11 at 7pm and Sunday, September 12 at 2pm.

Manganiello, a leader in the HIV/AIDS and civil rights movements, has lived with HIV for three and a half decades, deeply impacting his lens for medical research and patient advocacy. Through his work at Pyxis, he is on the frontlines of public health and research working with clients on advancing equitable participation in precision medicine solutions to disease, reducing stigma in the opioid crisis by advancing medication-assisted treatment, and protecting reproductive rights for all women in this country. His participation in FAUCI is an example of how he works to create nontraditional, trusted partnerships with key stakeholders to ensure that those who most need care have a voice and, like ACT UP did in the early days of AIDS, make marginalized Amercians trusted partners in the medical research paradigm to give them full and equitable access to health care services when they need them.

"This film beautifully captures the critical role patients play in advancing medical research and health policy; a sentiment Michael has instilled through all the work we do," said Ronnie Tepp and Bobby Clark, Principals at Pyxis Partners. "It's through passion, insights, and experiences such as these that Pyxis Partners is positioned to help the full range of organizations drive toward positive change and better health outcomes in the United States."

FAUCI is produced by Alexandra Moss (Not Done: Women Remaking America), Jon Bardin (All In: The Fight for Democracy), and executive produced by Academy Award® winner Dan Cogan (Icarus), and two-time Academy Award® nominee Liz Garbus (What Happened, Miss Simone?, The Farm: Angola, USA). The film will debut in select theaters that have mandated proof of vaccination for entrance, with masks also strongly encouraged, on September 10, 2021. Opening cities include New York, Los Angeles, San Francisco, Washington, D.C., and New Orleans.

More on Pyxis Partners

Pyxis Partners works to improve health outcomes for all Americans. Pyxis is a mission-driven organization fueled by passionate leaders in advocacy, engagement, and policy development. The Pyxis team has decades of experience working to advance progressive health policy issues at the federal level. Pyxis Partners' extensive and deep relationships with national research organizations, academic medical centers, foundations, health systems, industry, community-based and advocacy organizations, and across the federal government uniquely position us to help clients improve health equity, affordability, and accessibility in the United States.

SOURCE Pyxis Partners

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.